Non-steroidol anti-inflammatory drug effect on crypt cell proliferation and apoptosis during initiation of rat colon carcinogenesis
about
Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligandsEpigenetic impact of infection on carcinogenesis: mechanisms and applicationsAberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics.Colorectal cancer: molecules and populations.Apoptosis: implications for inflammatory bowel disease.Glucans from the edible mushroom Pleurotus pulmonarius inhibit colitis-associated colon carcinogenesis in mice.Understanding the interaction between environmental exposures and molecular events in colorectal carcinogenesis.Helicobacter pylori promote gastric cancer cells invasion through a NF-kappaB and COX-2-mediated pathwayNon-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort.Ibuprofen delivered by poly(lactic-co-glycolic acid) (PLGA) nanoparticles to human gastric cancer cells exerts antiproliferative activity at very low concentrationsDetermination of an optimal dosing regimen for aspirin chemoprevention of 1,2-dimethylhydrazine-induced colon tumours in rats.Fish oil supplementation enhanced CPT-11 (irinotecan) efficacy against MCF7 breast carcinoma xenografts and ameliorated intestinal side-effects.Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized studyCDK/CCN and CDKI alterations for cancer prognosis and therapeutic predictivity.COX-2 selective inhibition reverses the trophic properties of gastrin in colorectal cancer.R-flurbiprofen, a novel nonsteroidal anti-inflammatory drug, decreases cell proliferation and induces apoptosis in pituitary adenoma cells in vitro.Inhibition of Akt/PKB by a COX-2 inhibitor induces apoptosis in gastric cancer cells.Novel target for induction of apoptosis by cyclo-oxygenase-2 inhibitor SC-236 through a protein kinase C-beta(1)-dependent pathway.Colorectal cancer prevention in ulcerative colitis: a case-control study.Aspirin induces cell death and caspase-dependent phosphatidylserine externalization in HT-29 human colon adenocarcinoma cells.Resistance to apoptosis is a mechanism of adaptation of rat stomach to aspirin.COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors.The MEK/ERK pathway mediates COX-2-selective NSAID-induced apoptosis and induced COX-2 protein expression in colorectal carcinoma cells.Non-steroidal anti-inflammatory drugs inhibit nitric oxide-induced apoptosis and dedifferentiation of articular chondrocytes independent of cyclooxygenase activity.Suppression of implanted MDA-MB 231 human breast cancer growth in nude mice by dietary walnut.Sulindac corrects defective apoptosis and suppresses azoxymethane-induced colonic oncogenesis in p53 knockout mice.Inhibitors of prostaglandin synthesis do not improve food intake or body weight of tumor-bearing rats.Effect of Helicobacter pylori-induced cyclooxygenase-2 on gastric epithelial cell kinetics: implication for gastric carcinogenesis.Multivitamin and mineral supplementation in 1,2-dimethylhydrazine induced experimental colon carcinogenesis and evaluation of free radical status, antioxidant potential, and incidence of ACF.
P2860
Q24810709-4F3CC2A8-12AF-4405-81FB-EFDEABA02DB8Q28066519-640FF004-F7DA-4298-939D-54C21AAEFFB2Q30852730-CB095753-9365-4599-BE40-A5EC17925EA7Q33652932-FD4DE47C-43B8-4E70-B43D-664A943D892EQ34015892-010E4B5C-32DD-4EA4-8C37-D43EC2B753F3Q34029935-51BD77F9-9597-420F-A43B-6A21400C69B4Q34311096-97D6C54D-875B-4F9A-BD47-F38187E7F0F8Q35045577-AE5A373A-2023-4796-897B-212D005C0CD3Q35244467-EB4003D9-3371-4992-A8F0-F21F70EA79ACQ36398230-746E4514-83C3-41EF-8793-B210A425BA23Q36619280-35B20FF3-BFDC-4634-9379-E0C7A0BFDAA3Q36619832-1ABDF6A3-109A-45F9-A604-5232B036C42AQ37101384-358448A2-166B-483F-9180-E28EABBE1C81Q37586623-5A5FEA18-7380-437B-8DA5-31695BEACC50Q38290043-B03A4F41-94EF-4EAF-AB60-ACD313E1F14EQ39469974-0E9017B2-5312-4467-AFF7-AEB68994A20CQ40287095-4040996D-512F-4AE4-9686-224326A21AEAQ40636925-FFED2703-8B4E-4AE1-839D-AA60F97F8A3BQ41716716-93A8DF2E-99A7-48D8-8F66-B8A54D675E3DQ41971862-0F75A6D7-6E76-49C5-B50B-E89B2B575731Q42489347-5730763C-B33A-4071-B827-2C53A5531629Q43086302-FA610E36-0169-492A-A248-221EC37B0980Q43981126-4BD90B38-D18C-4D7C-9632-87EA0DB9545EQ44317021-594A5F87-5C26-4E94-AFAD-1246FAAFCFD3Q44941323-4ECB6566-9D4E-4640-8CEF-3332F8D09EB6Q46453863-379033E4-C49F-47EB-A149-A421BE941880Q47255745-4AF0C9BC-97BA-4412-B2B8-89CDA7E66B88Q52545901-4AA7AC4B-82D0-42B9-91A3-B981F0CF5840Q53277129-30A20B79-9D6F-4B2A-8F1D-5F84CDD919C5
P2860
Non-steroidol anti-inflammatory drug effect on crypt cell proliferation and apoptosis during initiation of rat colon carcinogenesis
description
1998 nî lūn-bûn
@nan
1998 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Non-steroidol anti-inflammator ...... on of rat colon carcinogenesis
@ast
Non-steroidol anti-inflammator ...... on of rat colon carcinogenesis
@en
Non-steroidol anti-inflammator ...... on of rat colon carcinogenesis
@nl
type
label
Non-steroidol anti-inflammator ...... on of rat colon carcinogenesis
@ast
Non-steroidol anti-inflammator ...... on of rat colon carcinogenesis
@en
Non-steroidol anti-inflammator ...... on of rat colon carcinogenesis
@nl
prefLabel
Non-steroidol anti-inflammator ...... on of rat colon carcinogenesis
@ast
Non-steroidol anti-inflammator ...... on of rat colon carcinogenesis
@en
Non-steroidol anti-inflammator ...... on of rat colon carcinogenesis
@nl
P2093
P2860
P356
P1476
Non-steroidol anti-inflammator ...... on of rat colon carcinogenesis
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1998.93
P407
P577
1998-02-01T00:00:00Z
P5875
P6179
1039529343